Arnold Palmer Hospital for Children- MD Anderson

Orlando, Florida 32806

0 studies enrolling now · 8 studies all time

What they study most

Brain Tumors, Medulloblastoma, Neuroblastoma, Neuroblastoma Recurrent, Rare Tumors, Relapse

Studies at this site

• Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma — Completed
• TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma — Completed
• Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide — Completed
• Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma — Completed
• Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma — Stopped early
• Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma — Stopped early
• Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer — Completed
• Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma — Completed